MarketPeel
Insider Trading Intelligence
CW

Christoph H. Westphal

TCRX
10% OWNER · TSCAN THERAPEUTICS, INC. · CIK 0001291961
FILING MIX · LIFETIME40%/60%
BUYS
2
SELLS
3
TOTAL VALUE
$2.00M
COMPANIES
1
ACTIVE SINCE
Jul 2021
HOLDINGS NOW
1,278,838
AVG SELL PX
TRADE KIND
SHOWING 5 / 5
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Christoph H. Westphal, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-9.52%+1.85%-11.37%-11.37%
14d1+100.00%+2.36%+2.34%+0.01%+0.01%
30d1+100.00%+0.09%+2.04%-1.95%-1.95%
60d1+0.00%-41.19%+2.73%-43.91%-43.91%
90d1+0.00%-38.36%+4.08%-42.44%-42.44%
180d1+0.00%-52.40%+8.54%-60.94%-60.94%
1y1+0.00%-66.92%-7.11%-59.80%-59.80%
2y1+0.00%-78.79%+8.13%-86.93%-86.93%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TCRX · 1,278,838 shares · as of Jul 20, 2021
0319,710639,419959,1291,278,838SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
FLOW · 2 buys / 3 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TCRX
TSCAN THERAPEUTICS, INC.
SALE
332,5940Jul 20, 2021Jul 22, 2021View →
TCRX
TSCAN THERAPEUTICS, INC.
SALE
641,8480Jul 20, 2021Jul 22, 2021View →
TCRX
TSCAN THERAPEUTICS, INC.
PURCHASE
1,145,5051,145,505Jul 20, 2021Jul 22, 2021View →
TCRX
TSCAN THERAPEUTICS, INC.
SALE
171,0630Jul 20, 2021Jul 22, 2021View →
TCRX
TSCAN THERAPEUTICS, INC.
PURCHASE
133,333$15.00$2.00M1,278,838Jul 20, 2021Jul 22, 2021View →
Other insiders · TCRX
Loading peer insiders…
About this filer
CIK 0001291961
ROLE
10% Owner
PRIMARY
TCRX
COMPANIES
1
ACTIVE SINCE
Jul 2021
MARKETPEEL · /INSIDER/0001291961DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback